CSE.THC OTC.THCBF F.TFHC
Vancouver, BC – (November 5, 2019)
THC BioMed Intl Ltd. (CSE:THC) (“THC BioMed” or the “Company”) has announced that it will hold an AGM on Tuesday, February 25, 2020.
In connection with its press release dated October 24, 2019, THC clarifies that it currently has 22 cannabis grow rooms and 13 cannabis processing rooms licensed by Health Canada. These rooms are in 14 of the Company’s 22 properties.
The Company made an additional application to Health Canada on October 25, 2019 for approval to use an additional lot for cannabis production. THC will make a further announcement when this application has been processed by Health Canada.
THC BioMed welcomes Roya Zarkob, its newest employee. Ms. Zarkob will work on marketing and certain investor relations activities for the Company. Ms. Zarkob is among the 35 additional employees that THC BioMed has added to its workforce this year, bringing its total staff to 50.
About THC
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. THC BioMed is Canada’s largest supplier of legal Cannabis Genetics. The Company is on the leading edge of scientific research and the development of products and services related to the medical cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.
Please visit our website for a more detailed description of our business and services available.
www.thcbiomed.com
President and CEO:
John Miller
THC Biomed Intl Ltd.
T: 1-844-THCMEDS
E: info@thcbiomed.com
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed Intl Ltd. (“THC”). Forward-looking information is based on certain key expectations and assumptions made by the management of THC. In some cases, you can identify forward-looking statements by the use of words such as “will,” “may,” “would,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “could” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this press release include that (a) THC will hold an AGM on February 25, 2020, (b) THC will make a further announcement when its recent application has been processed by Health Canada, (c) Ms. Zarkob will work on marketing and certain investor relations activities, and (d) THC will be in the forefront of this rapidly growing industry. Although THC believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forwardlooking information because THC can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.